InfuSystem Holdings, Inc. Stock

Equities

INFU

US45685K1025

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:00 2024-04-26 EDT 5-day change 1st Jan Change
8.12 USD +6.70% Intraday chart for InfuSystem Holdings, Inc. -0.98% -22.96%
Sales 2024 * 135M 185M Sales 2025 * 148M 202M Capitalization 173M 236M
Net income 2024 * 3M 4.1M Net income 2025 * 9M 12.3M EV / Sales 2024 * 1.27 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.17 x
P/E ratio 2024 *
52.4 x
P/E ratio 2025 *
19.3 x
Employees 508
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.70%
1 week-0.98%
Current month-5.25%
1 month-7.73%
3 months-15.68%
6 months-17.31%
Current year-22.96%
More quotes
1 week
7.57
Extreme 7.57
8.38
1 month
7.57
Extreme 7.57
8.89
Current year
7.57
Extreme 7.57
10.58
1 year
7.57
Extreme 7.57
11.44
3 years
6.10
Extreme 6.1
23.15
5 years
4.15
Extreme 4.15
23.26
10 years
1.20
Extreme 1.2
23.26
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 03-12-31
President 47 09-12-31
Director of Finance/CFO 53 20-03-11
Members of the board TitleAgeSince
Director/Board Member 67 22-05-16
Director/Board Member 77 14-05-07
Chairman 58 16-09-06
More insiders
Date Price Change Volume
24-04-26 8.12 +6.70% 27,842
24-04-25 7.61 -3.30% 30,441
24-04-24 7.87 -1.75% 18,683
24-04-23 8.01 +3.49% 12,517
24-04-22 7.74 -5.61% 75,317

Delayed Quote Nyse, April 26, 2024 at 04:00 pm

More quotes
InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.12 USD
Average target price
14.75 USD
Spread / Average Target
+81.65%
Consensus